Developing a blood test as accurate as a colonoscopy.

Making colorectal cancer screening easier for over 100 million Americans.

Founder & CEO

Joe Sedlak, Ph.D.
Harvard M.D./Ph.D. '25
Co-founder, Mercy BioAnalytics, led to FDA Breakthrough Device Designation in '24 for ovarian cancer screening.

Create the future of CRC screening

Contact us
Radiate BioSciences, Inc.
423 Brookline Ave., Suite 357
Boston, MA 02215

Joe@radiatebio.com
(617) 807-2158